The Block Firm has filed a class action lawsuit against Strides Pharma, alleging that the company distributed testosterone gel products contaminated with benzene, a known carcinogen. This legal action follows Strides Pharma’s recall of the affected products and aims to seek justice for consumers who may have been exposed to harmful substances.
Background
Benzene is a hazardous chemical linked to serious health issues, including leukemia and other blood disorders. Its presence in consumer products, especially pharmaceuticals, is strictly regulated due to its toxicity.
Strides Pharma’s recall of benzene-contaminated testosterone gel raises significant concerns about the company’s manufacturing practices and commitment to consumer safety. The use of benzene in drug manufacturing is prohibited, and its detection in Strides Pharma’s products indicates a severe lapse in quality control.
The Class Action
The Complaint, filed on May 19, 2025, in the Southern District of New York, alleges that Strides Pharma knowingly distributed testosterone gel containing benzene, endangering consumers’ health. The complaint details the company’s failure to adhere to safety standards and regulatory requirements, resulting in the distribution of contaminated products.
Legal Implications
This case underscores the importance of stringent quality control in pharmaceutical manufacturing. Companies are obligated to ensure their products are safe for consumer use, and failure to do so can lead to legal consequences and loss of public trust.
Your Rights
If you have used Strides Pharma’s testosterone gel and are concerned about potential exposure to benzene, you may be entitled to compensation. The Block Firm is committed to advocating for affected consumers and holding manufacturers accountable for negligence.
For more information or to join the class action lawsuit, please contact us. Our experienced legal team is here to assist you in understanding your rights and pursuing the justice you deserve.
